L-type calcium channels (Cav1.2)
Assets acting on this target.
- Class
- Dihydropyridine calcium channel blocker
- Notes
- mechanism wave 2026-08-24 (PubMed co-occurrence, 34 article(s)); source: https://pubmed.ncbi.nlm.nih.gov/40414594/
By indication
L-type calcium channels (Cav1.2) drugs compared
3 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| Nimodipine (Nimotop)Nimotop | Bayer, Laboratoire X.O | small molecule | Approved | Approved in Subarachnoid Hemorrhage |
| Nimodipine (GTx-104) | Grace Therapeutics | small molecule | Phase 3 | Phase 3 in Subarachnoid Hemorrhage |
| Lercanidipine | Lee's Pharmaceutical, Recordati | small molecule | Stage not recorded | Not recorded |